Screener
Harmony Biosciences Holdings, Inc. HRMY Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Harmony Biosciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The source filing: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 8:16 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056720
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Payments of employee withholding taxes related to stock-based awards | (2,565) | (1,308) |
| Proceeds from exercised options | 347 | 4,706 |
| Net cash used in financing activities | (7,218) | (352) |
| NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH | (163,104) | 35,997 |
| CASH, CASH EQUIVALENTS, AND RESTRICTED CASH—Beginning of period | 752,772 | 453,271 |
| CASH, CASH EQUIVALENTS, AND RESTRICTED CASH—End of period | $589,668 | $489,268 |
| Supplemental Disclosure of Cash Flow Information: | ||
| Cash paid during the year for interest | $3,324 | $4,197 |
Item 1. Financial Statements
FAQ
- What is Harmony Biosciences Holdings, Inc.'s net change in cash?
- Harmony Biosciences Holdings, Inc. (HRMY) reported net change in cash of -$163.1M in Q1 2026.
- How has Harmony Biosciences Holdings, Inc.'s net change in cash changed year-over-year?
- Harmony Biosciences Holdings, Inc.'s net change in cash decreased by 553.1% year-over-year, from $36M to -$163.1M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.
Ask your AI about Harmony Biosciences Holdings, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude